Ulcer treatment using choline esters of polysaccharides
    3.
    发明授权
    Ulcer treatment using choline esters of polysaccharides 失效
    使用多糖胆碱酯的溃疡治疗

    公开(公告)号:US5300493A

    公开(公告)日:1994-04-05

    申请号:US945495

    申请日:1992-09-16

    摘要: Acidic polysaccharide esters containing carboxylic groups are useful for protecting against and curing ulcers of the gastro-enteric system. These esters include choline esters with acidic polysaccharide selected from the group consisting of hyaluronic acid, alginic acid, gellan, oxidized cellulose, oxidized chitin, carboxy-hydrocarbyl-cellulose, carboxy-hydrocarbyl-starch and carboxy-hydrocarbyl-chitin, wherein the term hydrocarbyl means the residue of a hydrocarbon selected from the group consisting of by alkyl, aralkyl and cycloalkyl.

    摘要翻译: 含有羧基的酸性多糖酯可用于防止和治疗胃肠系统的溃疡。 这些酯包括选自透明质酸,海藻酸,结冷胶,氧化纤维素,氧化几丁质,羧基 - 烃基 - 纤维素,羧基 - 烃基 - 淀粉和羧基 - 烃基几丁质的酸性多糖的胆碱酯,其中术语烃基 是指选自烷基,芳烷基和环烷基的烃的残基。

    Carboxylic polysaccharide derivatives
    5.
    发明授权
    Carboxylic polysaccharide derivatives 失效
    羧酸多糖衍生物

    公开(公告)号:US5538730A

    公开(公告)日:1996-07-23

    申请号:US216858

    申请日:1994-03-24

    摘要: Copolymers of the formula: ##STR1## wherein the bonds between the glucoside units are .beta. (1.fwdarw.4), the degree of polymerization referred to a single glucoside unit varies from about 50 to 50,000, R is a free or esterified carboxy group and S is an amino or acylamino group. The part designated by x may vary between about 5% and 100% and that designated by y may vary between about 95% and 0%. At least a part of the R groups are esterified carboxy groups, and at least a part of the S groups are acylamino groups. Salts of these copolymers are also disclosed. The products of the invention are particularly useful in the cosmetic field.

    摘要翻译: 下式的共聚物:其中葡萄糖苷单元之间的键是β(1-> 4),所指的单糖苷单元的聚合度在约50至50,000之间变化,R是游离或酯化的羧基, S是氨基或酰氨基。 由x指定的部分可以在约5%和100%之间变化,并且由y指定的部分可以在约95%和0%之间变化。 R基团的至少一部分是酯化的羧基,并且至少一部分S基团是酰基氨基。 还公开了这些共聚物的盐。 本发明的产品在化妆品领域特别有用。

    Biomaterials for bone replacements
    6.
    发明授权
    Biomaterials for bone replacements 失效
    用于骨替代的生物材料

    公开(公告)号:US06533820B2

    公开(公告)日:2003-03-18

    申请号:US09335900

    申请日:1999-06-18

    IPC分类号: A61F228

    摘要: The present invention involves compositions for use as granular bone replacements. The compositions of the present invention are comprised of hyaluronic acid esters or salts of hyaluronic acid in association with a pharmacologically active compound wherein the molecular weight of the hyaluronic acid is below 250,000 and either artificial or natural bone granules. The present invention further involves a method of promoting the growth or repair of damaged or defective bones in either humans or animals using the compositions of hyaluronic acid derivatives and bone granules.

    摘要翻译: 本发明涉及用作粒状骨替代物的组合物。 本发明的组合物由透明质酸酯或透明质酸的盐与透明质酸的分子量低于25万的药物活性化合物和人造或天然骨颗粒组成。 本发明还涉及使用透明质酸衍生物和骨颗粒的组合物促进人或动物中损伤或有缺陷的骨骼的生长或修复的方法。

    Method of using low molecular weight hyaluronic acid for stimulating
bone formation
    8.
    发明授权
    Method of using low molecular weight hyaluronic acid for stimulating bone formation 失效
    使用低分子量透明质酸刺激骨形成的方法

    公开(公告)号:US5646129A

    公开(公告)日:1997-07-08

    申请号:US318804

    申请日:1995-01-17

    CPC分类号: C08B37/0072

    摘要: The present invention is drawn to hyaluronic acid fractions having molecular weights in the range of from about 20,000 to about 60,000 daltons, wherein these hyaluronic acid fractions possess osteoinductive activity. The present invention further includes pharmaceutical compositions comprising such hyaluronic acid fractions to be used in the treatment of various types of bone disorders, as well as methods of treating such disorders using the pharmaceutical compositions.

    摘要翻译: PCT No.PCT / EP93 / 00932 Sec。 371日期1995年1月17日 102(e)日期1995年1月17日PCT 1993年4月16日PCT公布。 出版物WO93 / 20827 日期:1993年10月28日本发明涉及分子量在约20,000至约60,000道尔顿范围内的透明质酸部分,其中这些透明质酸部分具有骨诱导活性。 本发明还包括药物组合物,其包含用于治疗各种类型的骨骼疾病的这种透明质酸组分,以及使用该药物组合物治疗此类病症的方法。